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Purpose: EGR1 (OMIM 128990) is an early growth response gene that has been shown to be related to myopia by
upregulation and down-regulation of axial eye growth in experimentally induced chicken myopia and knockout mice. The
purpose of this study was to test whether variations in the human EGR1 gene are related to high myopia.
Methods: Genomic DNA was prepared from leukocytes of peripheral blood. Cycle sequencing was used to detect
sequence variations in EGR1.
Results: No pathological mutations were detected upon sequencing of the coding regions and the adjacent intronic regions
of EGR1 in 96 unrelated Chinese subjects with high myopia. Only one silent variation, c.1026G>A (p.V342V), was
detected in one patients with high myopia, which would not affect the encoded protein. For all 96 subjects, only one allele
was detected in each of the three known single nucleotide polymorphisms (SNPs) in EGR1.
Conclusions: We found no evidence that EGR1 is responsible for high myopia in these patients.
Myopia is a leading visual problem that affects an average
of  one-third  of  the  world’s  population  with  the  highest
prevalence among East Asians [1-4]. The cost involved in
correcting  myopia  is  about  one-fourth  of  the  entire
expenditure  in  ophthalmology  and  optometry  [2,5].  Its
extreme form, high myopia, is the fourth most common cause
of irreversible blindness [6,7]. Evidence has demonstrated
that genetic factors play an important role in the development
of high myopia [1,8-11]. Molecular genetic investigations of
high  myopia  have  become  a  hot  topic  in  recent  years.
However, the genes responsible for most high myopia are, as
yet, unknown.
Expression of ZENK (the chicken and mouse ortholog of
mammalian EGR1, OMIM 128990) has been shown to be
involved  in  ocular  growth  and  refraction.  Experiments  in
animal models have shown that upregulation of ZENK in
retinal glucagon amacrine cells is assumed to create a STOP
signal to inhibit axial eye growth whereas down-regulation of
ZENK is associated with axial eye growth [12-16]. Therefore,
loss/reduction-of-function  mutation  of  ZENK  might
theoretically  be  associated  with  myopia.  Indeed,  EGR1
knockout mice had longer eyes and a relative myopic shift in
refraction [17]. Therefore, it would be interesting to know if
there  are  mutations  in  EGR1  of  human  individuals  with
myopia  especially  high  myopia  where  excessive  axial
elongation of the eye is a common prominent feature.
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Here, we analyzed EGR1 in 96 Chinese patients with high
myopia. No mutation was identified in EGR1. The results
indicate that EGR1 is unlikely to be responsible for high
myopia in these patients.
METHODS
Subjects: The procedure for collecting subjects and obtaining
informed consent was the same as previously described [18].
This study followed the tenets of the Declaration of Helsinki
and  was  approved  by  the  Institutional  Review  Board.
Ophthalmological  examinations  were  performed  by
ophthalmologists  (Q.Z.  and  X.G.).  A  total  of  96  Chinese
subjects  with  high  myopia  were  recruited  who  met  the
following criteria, 1) bilateral refraction of –6.00 D or lower
(spherical equivalent) and 2) did not have any other known
ocular or systemic disease. The refractive error was measured
with cycloplegic autorefraction after mydriasis (Mydrin®-P,
a compound tropicamide; Santen Pharmaceutical Co. Ltd.,
Osaka, Japan) for all eyes. Genomic DNA was prepared from
venous blood.
Mutation detection: Five pairs of primers (Table 1) were used
to amplify the two coding exons and the adjacent intronic
sequence of the EGR1 gene (NCBI human genome build 36.3,
NC_000005.8 for genomic DNA, NM_001964.2 for mRNA,
and  NP_001955.1  for  protein).  DNA  sequences  of  the
amplicons were identified with ABI BigDye Terminator cycle
sequencing kit version 3.1 (Applied Biosystems, Foster City,
CA) on an ABI 3100 Genetic Analyzer (Applied Biosystems).
Sequencing  results  from  patients  as  well  as  from  EGR1
consensus  sequences  from  the  NCBI  Human  Genome
Database (NC_000005.8) were imported into the SeqManII
program of the Lasergene package (DNAStar Inc., Madison,
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1309WI) and then aligned to identify variations. Each variation was
confirmed by bidirectional sequencing. Mutation description
followed  the  recommendation  of  the  Human  Genomic
Variation Society (HGVS) [19].
RESULTS
Clinical data: A total of 96 unrelated subjects (54 males and
42 females; mean age 17.07±17.01 years) participated in this
study. Refraction measures were −12.11±-4.55 D for the right
eye and −12.31±-4.81 D for the left eye.
Mutation analysis: Upon complete sequencing analysis of the
coding regions and the adjacent intronic regions, no mutation
was identified in the 192 chromosomes of EGR1 in the 96
subjects with high myopia. One silent variation, c.1026G>A
(p.V342V), was detected in one patients with high myopia.
This variation would not affect the encoded amino acid.
Single  nucleotide  polymorphism  analysis:  There  are  three
single nucleotide polymorphisms (SNPs) in EGR1 including
rs13181973,  rs11953917  (also  named  rs60458721),  and
rs1042088. For the 96 subjects with high myopia in this study,
only one allele was detected at each of the three SNPs, the C
allele for rs13181973, the G allele for rs11953917, and the C
allele for rs1042088. This is compatible with the HapMap
information for East Asians.
DISCUSSION
EGR1  is  an  early  growth  response  gene  that  encodes  a
transcription  factor,  Egr-1  protein,  or  ZENK.  ZENK
expression  can  be  upregulated  or  down-regulated  by
experimental interference that affects axial eye growth toward
hyperopia  or  myopia  in  chicken  and  monkey  [12-16].  A
knockout of both EGR1 alleles in C57/BL6 mice leads to
longer eyes and a relative myopic shift [17]. However, in
human beings, sequence analysis of EGR1 did not detect any
mutation in the 96 patients with high myopia. The results
suggest that EGR1 is unlikely to be the responsible gene for
high myopia in these patients.
Apart  from  EGR1,  myopia-like  changes  has  been
observed  in  lumican-fibromodulin  double  null  mice  [20].
Similarly, no mutation in the lumican and fibromodulin genes
has  been  identified  in  families  with  high  myopia  [21],
although a report claimed an association of myopia with SNPs
of lumican [22]. The situation in myopia knockout models is
different from other disease models such as Leber congenital
amaurosis and congenital stationary night blindness where
information obtained from animal models is compatible to
that from human diseases. In addition, human myopia may be
influenced by visual behavior and the visual environment,
which may differ greatly between animals and human beings.
This may raise the question to what extent does an animal
myopia model represent human myopia.
Identification of genes responsible for non-syndromic
high  myopia  is  very  important  but  will  be  very  difficult,
although several loci for high myopia have been mapped [6,
23-32]. Variations in several genes were reported to associate
with non-syndromic high myopia [22,33-37]. However, none
of these reports have been confirmed by replication study
[21,38-42], which is definitely the first priority in association
studies [43-47]. Two genes, TGFB-induced factor homeobox
1 (TGIF) and lumican, have been excluded as candidate genes
for high myopia, but they have still been treated as potential
candidate genes in several subsequent studies. False-positive
results in association studies have been frequently mistreated
as useful clues for subsequent studies in recent years, without
any replication study. Many researchers may have not realized
that most positive associations published (as high as 95%) are
false positives [43,45-49]. The most striking problem is the
criteria (p<5x10−2 or 1x10−2) that are inappropriately used to
claim an association. The false positive is still rather high even
using a more stringent criteria of about 10−5 suggested by
experts in the field [43,44,49-51]. Genetic association study
for complex traits is completely different from mapping a gene
for a Mendelian trait where, for the latter, a LOD score of 3
or more (2 or more for X-linked trait) is an indication of
TABLE 1. PRIMERS USED FOR POLYMERASE CHAIN REACTION AMPLIFICATION AND SEQUENCING OF EGR1.
Exon Primer sequence (5′-3′)
Size of PCR                   Annealing 
product (bp)                   temp (°C)                   Note
1 F-GTCGCCGCCTGCACGCTTCT
R-AAACCCGGCTCTCATTCTAA
550 64 GC Buffer
2a F-CCTCGGGAGTCAATGGTAG
R-GTGGGTGCCGCTGAGTAAATG
430 63 GC Buffer
2b F-ACCGGCCTCCTCGTCCTCA
R-ACTCCACTGGGCAAGCGTAAG
530 63
2c F-CTTCGCTAACCCCTCTGTCTA
R-GGTGGCCGGGGATGGATAAG
539 63
2d F-TGAACGCAAGAGGCATACCAA
R-GGCCATCTCCTCCTCCTGTCC
481 64 GC Buffer
GC buffer was provided by Takara Biotechnology (Dalian) Co. Ltd (Liaoning, China) and is designed for amplification of
templates  having complex secondary structure or high GC content. In the “Primer sequence” column, “F” indicates the forward
sequence and “R” indicates the reverse sequence.
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1310statistically significant linkage with a 5% chance of error
[52] (this has been well approved by identification of genes
responsible  for  human  Mendelian  traits  in  the  last  two
decades). In addition, proper classification of high myopia
into two groups, Mendelian trait (familial, congenital, or early
onset, moderate to high grade before school age, and myopic
fundus change) or complex trait (acquired, late-onset during
primary school, slow progress, and minimal or no fundus
change),  might  be  helpful  in  the  identification  of  genes
contributing to high myopia [53,54]. It would be very unusual
to conduct an association study for Mendelian traits with a
prominent heterogeneity such as retinitis pigmentosa, so why
is  it  acceptable  to  do  the  same  thing  for  Mendelian  high
myopia?
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